Direct and indirect effects of estrogen on osteoclasts

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 4, 2003, Pages 363-366

  Oursler, Merry Jo ^a,b  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Estrogen; Genomic responses; Non genomic responses; Osteoblasts; Osteoclasts

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN C FOS; PROTEIN C JUN; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE METABOLISM; CELL COUNT; CELL DIFFERENTIATION; CELL MEMBRANE DEPOLARIZATION; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN THERAPY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS;

EID: 1642513626     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142:5050-5055.
2. Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 2000; 26:653-661.
3. Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 2000; 15:640-649.
4. Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J Surg Res 2001; 100:18-24.
5. Massey HM, Scopes J, Horton MA, Flanagan AM. Transforming growth factor-beta1 (TGF-β) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 2001; 28:577-582.
6. Quinn JM, Itoh K, Udagawa N, Häusler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 2001; 16:1787-1794.
7. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N. The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 2001; 232:235-247; discussion 247-250.
8. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 1999; 25:517-523.
9. Wei S, Wang MW, Teitelbaum SL, Ross FP. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. J Biol Chem 2002; 277:6622-6630.
10. Saika M, Inoue D, Kido S, Matsumoto T. 17β-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinol 2001; 142:2205-2212.
11. Bord S, Ireland DC, Beavan SR, Compston JE. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003; 32:136-141.
12. Jilka RL, Hangoc C, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257:88-91.
13. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, MAnolagas SC. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the anti-osteoporotic effect of estrogens. J Clin Invest 1992; 89:883-891.
14. Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli LV, Peck WA. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc Natl Acad Sci USA 1989; 86:2398-2402.
15. Pacifici R, Brown C, Puscheck E, Friedrich E. Slatopolsky E, Maggio D, McCracken R, Avioli LV. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88:5134-5138.
16. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997; 12:935-941.
17. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period. Endocrinology 1995; 136:3054-3061.
18. Shaughnessy SG, Walton KJ, Deschamps P, Butcher M, Beaudin SM. Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice. Cytokine 2002; 20:78-85.
19. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 2003; 100:125-130.
20. Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002; 110:1643-1650.
21. Shinar DM, Rodan GA. Biphasic effects of transforming growth factor-β on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 1990; 126:3153-3158.
22. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995; 270:2008-2011.
23. Mundy GR. The effects of TGF-β on bone. Ciba Found Symp 1991; 157:137-143.
24. Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-β: enhancement by estrogen. J Cell Biochem 2002; 85:185-197.
25. Hughes DE, Wright KR, Mundy GR, Boyce BF. TGFβ1 induces osteoclast apoptosis in vitro. J Bone Miner Res 1994; 9:S138.
26. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 1996; 2:1132-1136.
27. Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T. Transforming growth factor-β 1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 1998; 252:747-752.
28. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsber TC. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17 β-estradiol and parathyroid hormone. Endocrinology 1991; 129:3313-3320.
29. Shevde NK, Bendixen AC, Dienger KM, Pike JW. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 2000; 97:7829-7834.
30. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 2001; 276:8836-8840.
31. Akatsu T, Murakami T, Nishikawa M, Ono K, Shinomiya N, Tsuda E. Mochizuki S, Yamaguchi K, Kinosaki M, Higashio K, Yamamoto M, Motoyoshi K, Nagata N. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 1998; 250:229-234.
32. Bell KL, Loveridge N, Lindsay PC, Lunt M, Garrahan N, Compston JE, Reeve J. Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone. J Bone Miner Res 1997; 12:1231-1240.
33. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK. Estrogen reduced the depth of resorption pits by disturbing organic bone matrix degradation activity of mature osteoclasts. Endocrinology 2001; 142:5371-5378.
34. Pensler JM, Radosevich JA, Higbee R, Langman CB. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res 1990; 5:797-802.
35. Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 1997; 20:87-92.
36. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 1991; 88:6613-6617.
37. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg T. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 1994; 91:5227-5231.
38. Mizuno Y, Hosoi T, Inoue S, Ikegami A, Kaneki M, Akedo Y, Nakamura T, Ouchi Y, Chang C, Orimo H. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcif Tissue Int 1994; 54:325-326.
39. Mano H, Yuasa T, Kameda T, Miqazawa K, Nakamaru Y, Shiokawa M, Mori Y, Yamada T, Miyata Km Shindo H, Azuma H, Hakeda Y, Kumegawa M. Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 1996; 223:637-642.
40. Brubaker KD, Gay CV. Specific binding of estrogen to osteoclast surfaces [published erratum appears in Biochem Biophys Res Commun 1994 15;202:643]. Biochem Biophys Res Commun 1994; 200:899-907.
41. Pascoe D, Oursler MJ. The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen. J Bone Miner Res 2001; 16:1028-1036.
42. Brubaker KD, Gay CV. Estrogen stimulates protein tyrosine phosphorylation and Src kinase activity in avian osteoclasts. J Cell Biochem 1999; 76:206-216.
43. Berger CE, Horrocks BR, Datta HK. Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts. Mol Cell Endocrinol 1999; 149:53-59.
44. Okabe K, Okamoto F, Kajiya H, Takada K, Soeda H. Estrogen directly acts on osteoclasts via inhibition of inward rectifier K+ channels. Naunyn Schmiedebergs Arch Pharmacol 2000; 361:610-620.
45. Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ. Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 1994; 58:1-9.